Evidence map›Paper›PMID 41760388›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Nanoparticles-Mediated Modulation of TRP Channels: Advances and Therapeutic Potential.

Karina A Foster, Noy Midler, Ori Shine, Dekel Rosenfeld

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Nanoparticles-Mediated Modulation of TRP Channels: Advances and Therapeutic Potential.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Karina A FosterThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Noy MidlerSchool of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Ori ShineFaculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Dekel RosenfeldThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.ORCID https://orcid.org/0000-0001-7350-9682

Funding

European Research Council 101116555Israel Science Foundation 1048/23Israel Science Foundation 2220/23Ministry of Science, Technology, and Space, Israel 1001576214Zuckerman STEM Leadership Program
6 · The paper itself

Abstract

Nanoparticles have emerged as promising tools for targeting and activating ion channels that serve as transducers for external signals. Their nanoscale dimensions enable targeted activation of ion channels at the cellular or subcellular level, offering unprecedented opportunities to control biological cell signaling. Recent works have demonstrated nanoparticle-mediated stimulation based on optical, electrical, and magnetic external signals, highlighting their potential to serve as minimally invasive therapeutics. In addition, there is an increasing need to identify relevant ion channels and their physiological role in advancing emerging nanotechnologies. The transient receptor potential (TRP) family, including prominent members such as the TRPV (vanilloid), TRPM (Melastatin), and TRPA (ankyrin), plays critical roles in physiological functions, such as temperature sensation, pain perception, and mechanical stimulus detection, and can be controlled via nanoparticle signaling. This review highlights the properties and roles of dominant TRP family members in different organs and positions them as relevant targets for novel technologies. Leveraging the knowledge of nanoparticle properties with recent advances in pharmacology and disease treatments that target TRP family members will enhance the development of novel nano-biotechnologies to control cell signaling.

Indexed as

NanoparticlesTransient Receptor Potential ChannelsAnimalsHumansTransient Receptor Potential Channelsheat‐sensitive ion channelsmechanosensitive ion channelsnanomaterialsnanotechnologyneuromodulationtransient receptor potential

Identifiers

PMID41760388
PMCPMC12948659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.